FDA Approvals, Highlights, and Summaries: Pulmonology 

February 24, 2021

Notable approvals

Breztri (budesonide/formoterol/glycopyrrolate inhaled) - New triple-combination aerosol inhaler approved for chronic obstructive pulmonary disease

Trelegy Ellipta (umeclidinium bromide/vilanterol inhaled/fluticasone furoate inhaled) - New indication for maintenance treatment of asthma

Bronchitol (mannitol inhalation) - New indication and brand for adults with cystic fibrosis as add-on maintenance therapy


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.